wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35896106-395EB431-D8DB-464A-871B-00E505E63386
Q35896106-395EB431-D8DB-464A-871B-00E505E63386
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35896106-395EB431-D8DB-464A-871B-00E505E63386
Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients: 48-week results from the REALMRK Study.
P2860
Q35896106-395EB431-D8DB-464A-871B-00E505E63386
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35896106-395EB431-D8DB-464A-871B-00E505E63386
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
410941928f45cf8851cb63640f921e7670722a0f
P2860
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials.